Skip to content

Ocular manifestations in rheumatologic diseases in adults

Ocular manifestations in rheumatologic diseases in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN41794974
Enrollment
1020
Registered
2023-09-27
Start date
2021-06-01
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatologic diseases Musculoskeletal Diseases

Interventions

A prospective, observational study was conducted in the Eye, Ear, and Nose Surgical Hospital from June 2020 to June 2023 on 300 adult patients with rheumatic disease. Demographic data

Sponsors

Damascus University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All patients with diagnosed rheumatic disease based on the diagnostic criteria, classified according to the International Classification of Disease, tenth edition (ICD-10) 2. Patients with ocular symptoms who presented to the Ophthalmology department, suspicious of connective tissue disease based on history and clinical examination, whose diagnosis was confirmed by the Rheumatology department

Exclusion criteria

Exclusion criteria: Ocular symptoms due to some other cause, pre-existing ocular disease, or comorbid illness like diabetes

Design outcomes

Primary

MeasureTime frame
1. Demographic data measured using a web survey at a single timepoint 2. Medical history regarding the disease diagnosed measured using a web survey at a single timepoint 3. Symptoms measured using a web survey at a single timepoint 4. Duration of the disease measured using a web survey at a single timepoint 5. Personal history measured using a web survey at a single timepoint 6. Family history of any systemic disease or other disease measured using a web survey at a single timepoint 7. Ocular symptoms measured using a web survey at a single timepoint

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

Syria

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026